TLDR Pseudopelade is a rare inherited hair loss condition with a genetic cause.
Pseudopelade was identified as a rare, idiopathic, progressive form of alopecia characterized by atrophy rather than true scarring, distinguishing it from other scarring alopecias. Despite lacking an initial inflammatory phase, it was classified among postinflammatory alopecias. A review of cases, particularly those with a family history, revealed a familial pattern, suggesting an autosomal dominant inheritance. The study highlighted the distinct nature of pseudopelade as a separate disease entity, marked by atrophic loss of hair follicles, with evidence from familial cases supporting a genetic etiology.
22 citations,
June 1980 in “International Journal of Dermatology” The document concludes that correct diagnosis of alopecia types is crucial, scalp biopsies are important, and more research is needed.
June 2023 in “Asian Journal of Pharmaceutical Research” Different types of hair loss require specific treatments, and new treatments are being developed.
1 citations,
August 2022 in “JAAD case reports” Tofacitinib and oral minoxidil may help treat Sisaipho alopecia areata.
April 2022 in “Journal of Cosmetic Dermatology” Trimax-360 Serum, when used for 98 days, safely and effectively improves hair growth, thickness, and density without any side effects.
5 citations,
January 2020 in “Journal of Dermatology” Temporal hair loss relates to overall scalp hair loss in women.
July 2013 in “DeckerMed Family Medicine” The document's conclusion cannot be provided because the document is not readable or understandable.
1 citations,
October 2011 in “PubMed” Teen hair loss is common, can be caused by genetics or health issues, and can be diagnosed and treated.
41 citations,
December 2008 in “International Journal of Dermatology” South Korean women with hair loss have lower hair density and thickness compared to healthy women.
5 citations,
October 1988 in “Clinics in Dermatology” Minoxidil promotes hair growth but exact mechanism is unknown.